BD and BioMedomics Launch Rapid Serology Test to Detect Exposure to COVID-19 in 15 Minutes

Shots:

• BioMedomic develops and manufactures the POC tests that will be available through BD and distributed exclusively by Henry Schein to the HCPs in the US
• The POC test detects Abs in the blood to confirm current or past exposure to COVID-19. The test has been clinically validated at several hospitals and clinical laboratories in both the US and China
• The test is completed in four, simple steps. First, blood is collected via blood collection devices like BD Microtainer Contact-Activated Lancet. A few drops of blood are then transferred to the test cartridge, followed by 2-3 drops of a buffer, with its expected result in 15mins showing multiple lines for positive results and a single line for negative results

Click here ­to­ read full press release/ article | Ref: BD | Image: BD